Dental Orthobiologics Market Growth Analysis 2025 To 2032

Posted 2026-03-12 09:26:43

Market Overview

The Dental Orthobiologics Market includes biologically derived materials and growth factors that promote healing and regeneration of dental tissues in surgical and non-surgical dental procedures. These products encompass bone grafts (autografts, allografts, xenografts, synthetic substitutes), growth factors, stem cells, and platelet-rich plasma (PRP), all of which are used in periodontal regeneration, maxillofacial reconstruction, implantology, and endodontics.

Key Players

ZimVie Inc. (U.S.), Institut Straumann AG (Switzerland), Envista (U.S.), Dentsply Sirona (U.S.), Henry Schein, Inc. (U.S.), Medtronic (Ireland), BioHorizons (U.S.), NovaBone (Halma) (U.K.), Geistlich Pharma AG (Switzerland), botiss biomaterials GmbH (Germany), curasan AG (Germany), Henry Schein, Inc. (U.S.), BioHorizons (U.S.), NovaBone (Halma) (U.K.), Geistlich Pharma AG (Switzerland)

Sample link - https://www.trendbridgeinsights.com/industry-report/dental-orthobiologics-market

Market segmentation:

Product Type

· Bone Graft Substitutes

· Bone Growth Factors

· Stem Cell Therapy

Application

· Dental Implants

· Periodontal Defects

· Alveolar Ridge Preservation

· Others

End-User

· Dental Clinics

· Hospitals

· Others

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming medical devices. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in medical devices is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis :

North America leads the dental orthobiologics market due to advanced regenerative dentistry and strong R&D. Europe follows with aging populations and implant demand. Asia-Pacific grows fastest driven by dental tourism and awareness. Latin America expands steadily, while MEA shows gradual growth led by urban private clinics amid rural access gaps.

Recent development :

In March 2025,Dentsply Sirona launched a synthetic bone graft substitute which provides enhanced handling characteristics while promoting osteoconduction to improve results in implant dentistry and periodontal surgeries.

FAQ:

1 . What is the projected market size & growth rate of the Dental Orthobiologics Market?

Dental Orthobiologics Market was valued at USD 1.35 billion in 2024 and is expected to reach to USD 12.9 billion by 2032, growing at a CAGR of 32.4% from 2025 to 2032.

2. What are the key driving factors for the growth of the Dental Orthobiologics Market?

Dental Orthobiologics Market is driven by Rising Dental Implant and Reconstructive Procedures, Technological Advancements in Grafting Materials, Aging Population and Periodontal Disease Prevalence, High Treatment and Material Costs, Stringent Regulatory Approvals, Storage and Handling Complexity, Growth in Dental Tourism and Emerging Markets, Innovation in Stem Cell Therapies, Rising Adoption of PRP and Autologous Solutions, Limited Clinical Evidence and Acceptance, Risk of Disease Transmission in Allografts and Xenografts, Lack of Skilled Practitioners.

3. What are the top players operating in the Dental Orthobiologics Market?

The major players in the market are ZimVie Inc. (U.S.), Institut Straumann AG (Switzerland), Envista (U.S.), Dentsply Sirona (U.S.), Henry Schein, Inc. (U.S.), Medtronic (Ireland), BioHorizons (U.S.), NovaBone (Halma) (U.K.), Geistlich Pharma AG (Switzerland), botiss biomaterials GmbH (Germany), curasan AG (Germany)

4. What segments are covered in the Dental Orthobiologics Market?

The Global Dental Orthobiologics Market is segmented based on Product Type, Application, End-User, and Geography.

About US: